Abstract
Cocaine was brought to Europe after the discovery of America. In the 19th century, the active component of coca leaves, named cocaine, was extracted and several researchers started experimenting with the substance, describing many physiological and pathological effects of its action. The first scholar to practically demonstrate the possibility of using cocaine solution in medicine, mostly ophthalmology, was Carl Koller. Following this remarkable achievement cocaine became the substance most frequently applied for different types of anaesthesia. Halsted and Hall reported the first successful nerve block of the interior dental nerve with 4% cocaine solution. In 1892, Schleich published the results of his studies in which he used a 0.1–0.2% solution of cocaine hydrochloride intra- and subcutaneously, introducing the so-called infiltration anaesthesia. At the end of the 19th century it was, however, demonstrated that cocaine possessed many undesirable effects, including addiction, which triggered off interest in other, less toxic, anaesthetics.
References
1.
Calatayud J, Gonzales A: History of the development and revolution of local anesthesia since the coca leaf. Anesthesiology 2003;98:1503–1508.
2.
Fink BR: Leaves and needles: the introduction of surgical local anesthesia. Anesthesiology 1985;63:77–83.
3.
Grzybowski A: Historia zainteresowania tytoniem i nikotynizmem do połowy XX wieku w Europie (The history of interest in tobacco and nicotinism until mid-20th century in Europe). Przeglą;d Lekarski 2005;62:1211–1214.
4.
Pöppig E: Reise in Chile, Peru und auf dem Amazonenstrome während der Jahre 1827–1832. Leipzig, Fleischer & JC Hinrichssche Buchhandlung, 1836.
5.
Niemann A: Ueber eine neue organische Base in den Cocablättern. Arch Pharm 1860;153:129–155, 291–308.
6.
Lossen W: Ueber das Cocain. Ann Chem Pharm 1865;133:351–371.
7.
Willstätter R: Ueber die Constitution der Spaltungsproducte von Atropin und Cocain. Ber Dtsch Chem Ges 1898;31:1534–1553.
8.
Willstätter R, Wolfes D, Mäder H: Synthese des natürlichen Cocains. Justus Liebigs Ann Chem 1923;434:111–139.
9.
Moréno y Maïz T: Recherches chimiques et physiologiques sur l’erythroxylum coca du Perou et la cocaine. Paris, Leclerc, 1868.
10.
Marret E, Gentili M, Bonnet F: Moreno y Maiz: a missed rendezvous with local anesthesia. Anesthesiology 2004;5:1321–1322.
11.
Von Anrep B: Ueber die physiologische Wirkung des Cocain. Pflügers Arch Ges Physiol 1880;21:38–77.
12.
Koller C: Historical notes on the beginning of local anesthesia. J Am Med Assoc 1928;90:1742–1743.
13.
Koller K: Ueber die Verwendung des Cocain zur Anästhesierung am Auge. Wien Med Wochenschr 1884;34:1276–1278, 1309–1311.
14.
Noyes HD: The ophthalmological congress in Heidelberg. Med Rec 1884;26:417–418.
15.
Koller C: On the use of cocaine for producing anaesthesia on the eye. Lancet 1884;2:990–992.
16.
Loewenfeld IE: The Pupil. Anatomy, Physiology, and Clinical Applications. Boston, Butterworth-Heinemann, 1999.
17.
Uthoff W: Zur diagnostischen Bedeutung der reflectorischen Pupillenstarre. Berl Klin Wochenschr 1886;23:12–13, 36–40, 54–56.
18.
Hall RJ: Hydrochlorate of cocaine. NY Med J 1884;40:643–644.
19.
Yentis SM, Vlassakov KV: Vassily von Anrep, forgotten pioneer of regional anesthesia. Anesthesiology 1999;90:890–895.
20.
Pernice L: Ueber Cocainanästhesie. Dtsch Med Wochenschr 1890;16:287–289.
21.
Schleich CL: Infiltrationsanästhesie (locale Anästhesie) und ihr Verhältnis zur allgemeinen Narcose (Inhalationsanästhesie). Verh Dtsch Ges Chir 1892;21:121–127.
22.
Anonymus: Cocaine. BMJ 1979;1:971–972.
23.
Mitchell JD, Schwartz AL: Acute angle-closure glaucoma associated with intranasal cocaine abuse. Am J Ophthalmol 1996;122:425–426.
24.
Hari CK, Roblin DG, Clayton MI, Nair RG: Acute angle closure glaucoma precipitated by intranasal application of cocaine. J Laryngol Otol 1999;113:250–251.
25.
Wilcsek GA, Vose MJ, Francis IC, Sharma S, Coroneo MT: Acute angle closure glaucoma following the use of intranasal cocaine during dacryocystorhinostomy. Br J Ophthalmol 2002;86:1312.
26.
Freedman KA, Brown SM: Topical apraclonidine in the diagnosis of suspected Horner syndrome. J Neuroophthalmol 2005;25:83–85.
27.
Daniels J, Baker DG, Norman AB: Cocaine-induced tics in untreated Tourette’s syndrome. Am J Psychiatry 1996;153:965.
28.
Cardoso FE, Jankovic J: Cocaine-related movement disorders. Mov Disord 1993;8:175–178.
29.
Linazasoro G, Van Blercom N: Severe stuttering and motor tics responsive to cocaine. Parkinsonism Relat Disord 2007;13:57–58.
30.
DiRocco A, Nasser S, Werner P: Inhaled cocaine used to relieve ‘off’ periods in patients with Parkinson disease and unpredictable motor fluctuations: a report of 2 cases. J Clin Psychopharmacol 2006;26:689–690.
31.
Sawada H, Yamakawa K, Yamakado H, Hosokawa R, Ohba M, Miyamoto K, Kawamura T, Shimohama S: Cocaine and phenylephrine eye drop test for Parkinson disease. JAMA 2005;293:932–934.
© 2008 S. Karger AG, Basel
2008
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.
